Brussels, Belgium

Marc Zeicher


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1991-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marc Zeicher

Introduction

Marc Zeicher is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of radiotherapy and imaging through his innovative patents. With a total of two patents to his name, Zeicher's work is recognized for its potential impact on medical science.

Latest Patents

Marc Zeicher's latest patents include compounds that are particularly useful for radiotherapy or imaging. One of his notable inventions involves specific ligands for estrogen and progestagen steroid hormone receptors. This invention relates to specific ligands that have a unique formula, where X denotes a vinyl group substituted by a radioactive or nonradioactive halogen on the double bond according to Z isomerism. These advancements showcase his commitment to enhancing medical technologies.

Career Highlights

Throughout his career, Marc Zeicher has demonstrated a strong dedication to research and innovation. His work at Ire-Celltarg S.A. has allowed him to explore new frontiers in medical applications. His contributions are vital in the ongoing development of effective treatments and diagnostic tools.

Collaborations

Marc Zeicher has collaborated with esteemed colleagues such as Jacques Quivy and Manuel Worcel. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

In summary, Marc Zeicher is an influential inventor whose work in the field of radiotherapy and imaging has the potential to transform medical practices. His innovative patents and collaborative efforts highlight his significant contributions to science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…